Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis
Welton, Joanne Louise
von Ruhland, Chris
Taylor & Francis
MetadataShow full item record
The discovery of disease biomarkers, along with the use of “liquid biopsies” as a minimally invasive source of biomarkers, continues to be of great interest. In inflammatory diseases of the central nervous system (CNS), cerebrospinal fluid (CSF) is the most obvious biofluid source. Extracellular vesicles (EVs) are also present in CSF and are thought to be potential “biomarker treasure chests”. However, isolating these CSF-derived EVs remains challenging. This small-scale pilot study developed and tested a protocol to enrich for CSF-EVs, both in relapsing remitting multiple sclerosis (RRMS) CSF and controls. These were subsequently compared, using an aptamer based proteomics array, SOMAscan™. EVs were enriched from RRMS patient (n = 4) and non-demyelinating control (idiopathic intracranial hypertension (IIH) (n = 3)) CSF using precipitation and mini size-exclusion chromatography (SEC). EV-enriched fractions were selected using pre-defined EV characteristics, including increased levels of tetraspanins. EVs and paired CSF were analysed by SOMAscan™, providing relative abundance data for 1128 proteins. CSF-EVs were characterised, revealing exosome-like features: rich in tetraspanins CD9 and CD81, size ~100 nm, and exosome-like morphology by TEM. Sufficient quantities of, SOMAscan™ compatible, EV material was obtained from 5 ml CSF for proteomics analysis. Overall, 348 and 580 proteins were identified in CSF-EVs and CSF, respectively, of which 50 were found to be significantly (t-test) and exclusively enriched in RRMS CSF-EVs. Selected proteins, Plasma kallikrein and Apolipoprotein-E4, were further validated by western blot and appeared increased in CSF-EVs compared to CSF. Functional enrichment analysis of the 50 enriched proteins revealed strong associations with biological processes relating to MS pathology and also extracellular regions, consistent with EV enrichment. This pilot study demonstrates practicality for EV enrichment in CSF derived from patients with MS and controls, allowing detailed analysis of protein profiles that may offer opportunities to identify novel biomarkers and therapeutic approaches in CNS inflammatory diseases
Journal of Extracellular Vesicles;
Welton, J.L., Loveless, S., Stone, T., von Ruhland, C., Robertson, N.P. and Clayton, A. (2017) 'Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis', Journal of Extracellular Vesicles, 6(1), p.1369805.
This short communication was published in Journal of Extracellular Vesicles on 03 September 2017 available open access at https://doi.org/10.1080/20013078.2017.1369805
Cardiff Metropolitan University (Grant ID: Cardiff Metropolian (Internal))
Multiple Sclerosis Society [Grant reference 13].
Showing items related by title, author, subject and abstract.
Ambler, Nicola (University of Wales Institute Cardiff, 2012)Introduction: Prostate cancer is the second most commonly diagnosed cancer in men worldwide. Currently the biomarker used to diagnose and manage prostate cancer is Prostate Specific Antigen (PSA). Due to its associated ...
Welton, Joanne Louise; Webber, Jason Paul; Botos, Laur-Alexandru; Jones, Michael; Clayton, Aled (Co-action Publishing, 2015)Proteomic studies of circulating vesicles are hampered by difficulties in purifying vesicles from plasma and serum. Isolations are contaminated with high-abundance blood proteins that may mask genuine vesicular-associated ...
'In search of ‘Omics'-based biomarkers to predict risk of frailty and its consequences in older individuals: the FRAILOMIC initiative Erusalimsky, Jorge; Grillari, Johannes; Grune, Tilman; Jansen-Duerr, Pidder; Lippi, Giuseppe; Sinclair, Alan; Tegner, Jesper; Vina, Jose; Durrance-Bagale, Anna; Minambres, Rebecca; Viegas, Marcelo; Rodriguez-Manas, Leocadio (Karger, 2016)An increase in the number of older people experiencing disability and dependence is a critical aspect of the demographic change that will emerge within Europe due to the rise in life expectancy. In this scenario, prevention ...